• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ACW

ACTINOGEN MEDICAL LIMITED - Announcements

3.70% ! 2.8¢
Market Cap $88.91M  !

Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel... Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological diseases associated with dysregulated brain cortisol. There is a strong association between cortisol and detrimental changes in the brain, affecting cognitive function, harm to brain cells and long term cognitive health.More

Recently Updated

Corporate Spotlight

Actinogen is a neurotherapeutics developer realizing a revolutionary therapy so neurology patients and their families can live their best lives.
View the full Corporate Spotlight arrow Created with Sketch.

Actinogen reaches 100th participant milestone

Announcements



ACW ACW secures shortfall commitments of $4.56m for rights issuePRICE SENSITIVE15/08/23 download Created with Sketch. 222.88KB
ACW Entitlement Offer ProspectusPRICE SENSITIVE08/08/23 download Created with Sketch. 1.26MB
ACW Proposed issue of securities - ACW02/08/23 download Created with Sketch. 33.77KB
ACW Actinogen announces $10 million rights offerPRICE SENSITIVE02/08/23 download Created with Sketch. 259.74KB
ACW Quarterly Activity Report & Appendix 4CPRICE SENSITIVE31/07/23 download Created with Sketch. 330.43KB
ACW Trading HaltPRICE SENSITIVE31/07/23 download Created with Sketch. 642.62KB
ACW ACW CEO presents at Bioshares Biotech Summit25/07/23 download Created with Sketch. 2.7MB
ACW Actinogen CMO presents academic poster to AAIC Conference17/07/23 download Created with Sketch. 622.82KB
ACW ACW CEO presentation on emerging oral Alzheimers therapies21/06/23 download Created with Sketch. 1.49MB
ACW ACW CEO & CMO present at BIO International Convention05/06/23 download Created with Sketch. 1.52MB
ACW ACW AD trial amendment and Clinical Science Forum slidesPRICE SENSITIVE24/05/23 download Created with Sketch. 1.69MB
ACW Quarterly Activity Report & Appendix 4CPRICE SENSITIVE24/04/23 download Created with Sketch. 325.71KB
ACW Actinogen CMO presents at ADPD 2023 conference31/03/23 download Created with Sketch. 1.38MB
ACW Application for quotation of securities - ACW20/03/23 download Created with Sketch. 26.61KB
ACW Appendix 3X - Dr Nicki Vasquez01/03/23 download Created with Sketch. 149.99KB
ACW ACW appoints Dr Nicki Vasquez as a Non-Executive Director01/03/23 download Created with Sketch. 244KB
ACW Actinogen CEO presents to Spark Plus Biotech conference24/02/23 download Created with Sketch. 1.71MB
ACW Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE22/02/23 download Created with Sketch. 1.33MB
ACW Actinogen appoints Dr Dana Hilt as Chief Medical Officer01/02/23 download Created with Sketch. 240.38KB
ACW Quarterly Activity Report & Appendix 4CPRICE SENSITIVE30/01/23 download Created with Sketch. 389.51KB
ACW ACW CEO presentation Sachs Neuroscience and JPM week09/01/23 download Created with Sketch. 1.54MB
ACW Letter to Shareholders - CEO 2022 Review & Outlook22/12/22 download Created with Sketch. 394.21KB
ACW FDA agrees to six-month Phase 2b Alzheimers Disease TrialPRICE SENSITIVE22/12/22 download Created with Sketch. 235.52KB
ACW Cleansing Notice09/12/22 download Created with Sketch. 205.68KB
ACW Application for quotation of securities - ACW09/12/22 download Created with Sketch. 24.71KB
ACW First patient treated in XanaCIDD Phase 2 Depression TrialPRICE SENSITIVE08/12/22 download Created with Sketch. 230.87KB
ACW Actinogen poster presentation at CTAD conference 202205/12/22 download Created with Sketch. 516.21KB
ACW Constitution16/11/22 download Created with Sketch. 424.43KB
ACW Results of AGM16/11/22 download Created with Sketch. 234.15KB
ACW Actinogen AGM Chair address & CEO presentation16/11/22 download Created with Sketch. 2.42MB
ACW Appendix 3Y - Dr George Morstyn11/11/22 download Created with Sketch. 192.7KB
ACW Cleansing Notice11/11/22 download Created with Sketch. 204.85KB
ACW Application for quotation of securities - ACW11/11/22 download Created with Sketch. 24.76KB
ACW ACW CEO presentation to Bell Potter Healthcare Conference09/11/22 download Created with Sketch. 2.76MB
ACW Appendix 3Y - Dr Steven Gourlay04/11/22 download Created with Sketch. 190.59KB
ACW Actinogen CEO presentation to Spark Plus Healthcare Day03/11/22 download Created with Sketch. 2.31MB
ACW Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/10/22 download Created with Sketch. 489.86KB
ACW Actinogen CEO presentation to ShareCafe investor webinar21/10/22 download Created with Sketch. 2.04MB
ACW R&D tax incentive rebate receivedPRICE SENSITIVE20/10/22 download Created with Sketch. 204.95KB
ACW Annual Report to Shareholders14/10/22 download Created with Sketch. 7.5MB
ACW Letter to Shareholders, Notice of AGM & Proxy Form14/10/22 download Created with Sketch. 854.98KB
ACW ACW clinical biomarker study webcast presentationPRICE SENSITIVE10/10/22 download Created with Sketch. 2.4MB
ACW ACW announces positive Alzheimers Disease clinical resultsPRICE SENSITIVE10/10/22 download Created with Sketch. 300.23KB
ACW Trading HaltPRICE SENSITIVE06/10/22 download Created with Sketch. 272.6KB
ACW Date of AGM and Closing Date for Director Nominations28/09/22 download Created with Sketch. 204.74KB
ACW Actinogen AD Biomarkers Context & History Presentation13/09/22 download Created with Sketch. 2.94MB
ACW Appendix 4G25/08/22 download Created with Sketch. 285.67KB
ACW Corporate Governance Statement25/08/22 download Created with Sketch. 380.16KB
ACW Actinogen FY22 Results - Accelerating Clinical DevelopmentPRICE SENSITIVE25/08/22 download Created with Sketch. 254.15KB
ACW ACW Appendix 4E and 2022 Annual ReportPRICE SENSITIVE25/08/22 download Created with Sketch. 4.92MB
ACW Actinogen Spark Plus non deal roadshow investor presentation11/08/22 download Created with Sketch. 1.9MB
ACW Actinogen Clinical Trials Science Forum presentation slides03/08/22 download Created with Sketch. 5.15MB
ACW ACW CEO presentation to Spark Plus Aust Equities Day28/07/22 download Created with Sketch. 3.3MB
ACW Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/07/22 download Created with Sketch. 348.85KB
ACW ACW CEO to present at Spark Plus Aust Equities Day25/07/22 download Created with Sketch. 218.79KB
ACW Actinogen Clinical Trials Science Forum Save the Date21/07/22 download Created with Sketch. 217.82KB
ACW Application for quotation of securities - ACW15/07/22 download Created with Sketch. 26.29KB
ACW Actinogen Alzheimer Disease Biomarker Study Timing & Design13/07/22 download Created with Sketch. 257.67KB
ACW ACW Presentation for BIO International Convention meetings14/06/22 download Created with Sketch. 4.01MB
ACW ACW announces Phase 2 trial designs for AD & MDDPRICE SENSITIVE14/06/22 download Created with Sketch. 556.64KB
ACW Change in substantial holding01/06/22 download Created with Sketch. 181.96KB
ACW Application for quotation of securities - ACW24/05/22 download Created with Sketch. 26.8KB
ACW Appendix 3Y - Dr Geoff Brooke24/05/22 download Created with Sketch. 192.25KB
ACW Appendix 3Y - Dr Steven Gourlay13/05/22 download Created with Sketch. 191.3KB
ACW Actinogen presentation to Bioshares Biotech Summit 202211/05/22 download Created with Sketch. 2.33MB
ACW Actinogen trial results & strategic update presentationPRICE SENSITIVE04/05/22 download Created with Sketch. 2.29MB
ACW Actinogen prioritizes Alzheimers Disease & DepressionPRICE SENSITIVE04/05/22 download Created with Sketch. 243.81KB
ACW Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/04/22 download Created with Sketch. 814.14KB
ACW ACW positive XanaMIA results webcast slide presentationPRICE SENSITIVE27/04/22 download Created with Sketch. 2.07MB
ACW ACW announces positive XanaMIA results for XanamemPRICE SENSITIVE27/04/22 download Created with Sketch. 250.85KB
ACW Trading HaltPRICE SENSITIVE22/04/22 download Created with Sketch. 679.48KB
ACW Appendix 3Y - Dr Steven Gourlay06/04/22 download Created with Sketch. 190.89KB
ACW Cleansing Notice06/04/22 download Created with Sketch. 341.02KB
ACW Application for quotation of securities - ACW06/04/22 download Created with Sketch. 24.66KB
ACW Results of Meeting05/04/22 download Created with Sketch. 222.14KB
ACW Letter to Shareholders & Notice of General Meeting02/03/22 download Created with Sketch. 873.76KB
ACW ACW CEO Presents at European Life Sciences Conference01/03/22 download Created with Sketch. 2.21MB
ACW Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE24/02/22 download Created with Sketch. 975.13KB
ACW Actinogen appoints Prof Paul Rolan as Chief Medical Officer15/02/22 download Created with Sketch. 232.96KB
ACW Actinogen XanaMIA Part A trial results expected in AprilPRICE SENSITIVE11/02/22 download Created with Sketch. 256.29KB
ACW Actinogen appoints XanaFX Phase 2 trial managerPRICE SENSITIVE09/02/22 download Created with Sketch. 259.28KB
ACW Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/01/22 download Created with Sketch. 496.77KB
ACW Application for quotation of securities - ACW13/01/22 download Created with Sketch. 26.3KB
ACW ACW CEO Presents at San Francisco Healthcare Conference10/01/22 download Created with Sketch. 7.51MB
ACW Appendix 3Y - Mr Malcolm McComas21/12/21 download Created with Sketch. 192.48KB
ACW Appendix 3Y - Dr George Morstyn21/12/21 download Created with Sketch. 192.27KB
ACW Appendix 3Y - Dr Geoff Brooke21/12/21 download Created with Sketch. 192.49KB
ACW Application for quotation of securities - ACW20/12/21 download Created with Sketch. 24.78KB
ACW Capital Raising CompletionPRICE SENSITIVE20/12/21 download Created with Sketch. 236KB
ACW New clinical advisory boards09/12/21 download Created with Sketch. 252.73KB
ACW ACW Strategic Collaboration with Oxford Uni ResearchersPRICE SENSITIVE07/12/21 download Created with Sketch. 180.98KB
ACW Cleansing Notice01/12/21 download Created with Sketch. 246.86KB
ACW Application for quotation of securities - ACW30/11/21 download Created with Sketch. 23.42KB
ACW Offer to Participate in Share Purchase Plan29/11/21 download Created with Sketch. 262.44KB
ACW Share Purchase Plan Offer Booklet29/11/21 download Created with Sketch. 305.76KB
ACW Cleansing Notice - Share Purchase Plan29/11/21 download Created with Sketch. 237.75KB
ACW XanaMIA Part A trial achieves target enrolmentPRICE SENSITIVE29/11/21 download Created with Sketch. 204.1KB
ACW Cleansing Notice - Share Purchase Plan25/11/21 download Created with Sketch. 224.16KB
ACW Proposed issue of securities - ACW25/11/21 download Created with Sketch. 36.97KB
ACW Strategic Update & Capital Raising Investor PresentationPRICE SENSITIVE25/11/21 download Created with Sketch. 6.5MB
ACW ACW secures shortfall commitments of $4.56m for rights issue
15/08/23PRICE SENSITIVE download Created with Sketch. 222.88KB
ACW Entitlement Offer Prospectus
08/08/23PRICE SENSITIVE download Created with Sketch. 1.26MB
ACW Proposed issue of securities - ACW
02/08/23 download Created with Sketch. 33.77KB
ACW Actinogen announces $10 million rights offer
02/08/23PRICE SENSITIVE download Created with Sketch. 259.74KB
ACW Quarterly Activity Report & Appendix 4C
31/07/23PRICE SENSITIVE download Created with Sketch. 330.43KB
ACW Trading Halt
31/07/23PRICE SENSITIVE download Created with Sketch. 642.62KB
ACW ACW CEO presents at Bioshares Biotech Summit
25/07/23 download Created with Sketch. 2.7MB
ACW Actinogen CMO presents academic poster to AAIC Conference
17/07/23 download Created with Sketch. 622.82KB
ACW ACW CEO presentation on emerging oral Alzheimers therapies
21/06/23 download Created with Sketch. 1.49MB
ACW ACW CEO & CMO present at BIO International Convention
05/06/23 download Created with Sketch. 1.52MB
ACW ACW AD trial amendment and Clinical Science Forum slides
24/05/23PRICE SENSITIVE download Created with Sketch. 1.69MB
ACW Quarterly Activity Report & Appendix 4C
24/04/23PRICE SENSITIVE download Created with Sketch. 325.71KB
ACW Actinogen CMO presents at ADPD 2023 conference
31/03/23 download Created with Sketch. 1.38MB
ACW Application for quotation of securities - ACW
20/03/23 download Created with Sketch. 26.61KB
ACW Appendix 3X - Dr Nicki Vasquez
01/03/23 download Created with Sketch. 149.99KB
ACW ACW appoints Dr Nicki Vasquez as a Non-Executive Director
01/03/23 download Created with Sketch. 244KB
ACW Actinogen CEO presents to Spark Plus Biotech conference
24/02/23 download Created with Sketch. 1.71MB
ACW Appendix 4D & Half-Year Financial Statements
22/02/23PRICE SENSITIVE download Created with Sketch. 1.33MB
ACW Actinogen appoints Dr Dana Hilt as Chief Medical Officer
01/02/23 download Created with Sketch. 240.38KB
ACW Quarterly Activity Report & Appendix 4C
30/01/23PRICE SENSITIVE download Created with Sketch. 389.51KB
ACW ACW CEO presentation Sachs Neuroscience and JPM week
09/01/23 download Created with Sketch. 1.54MB
ACW Letter to Shareholders - CEO 2022 Review & Outlook
22/12/22 download Created with Sketch. 394.21KB
ACW FDA agrees to six-month Phase 2b Alzheimers Disease Trial
22/12/22PRICE SENSITIVE download Created with Sketch. 235.52KB
ACW Cleansing Notice
09/12/22 download Created with Sketch. 205.68KB
ACW Application for quotation of securities - ACW
09/12/22 download Created with Sketch. 24.71KB
ACW First patient treated in XanaCIDD Phase 2 Depression Trial
08/12/22PRICE SENSITIVE download Created with Sketch. 230.87KB
ACW Actinogen poster presentation at CTAD conference 2022
05/12/22 download Created with Sketch. 516.21KB
ACW Constitution
16/11/22 download Created with Sketch. 424.43KB
ACW Results of AGM
16/11/22 download Created with Sketch. 234.15KB
ACW Actinogen AGM Chair address & CEO presentation
16/11/22 download Created with Sketch. 2.42MB
ACW Appendix 3Y - Dr George Morstyn
11/11/22 download Created with Sketch. 192.7KB
ACW Cleansing Notice
11/11/22 download Created with Sketch. 204.85KB
ACW Application for quotation of securities - ACW
11/11/22 download Created with Sketch. 24.76KB
ACW ACW CEO presentation to Bell Potter Healthcare Conference
09/11/22 download Created with Sketch. 2.76MB
ACW Appendix 3Y - Dr Steven Gourlay
04/11/22 download Created with Sketch. 190.59KB
ACW Actinogen CEO presentation to Spark Plus Healthcare Day
03/11/22 download Created with Sketch. 2.31MB
ACW Quarterly Activity Report & Appendix 4C
28/10/22PRICE SENSITIVE download Created with Sketch. 489.86KB
ACW Actinogen CEO presentation to ShareCafe investor webinar
21/10/22 download Created with Sketch. 2.04MB
ACW R&D tax incentive rebate received
20/10/22PRICE SENSITIVE download Created with Sketch. 204.95KB
ACW Annual Report to Shareholders
14/10/22 download Created with Sketch. 7.5MB
ACW Letter to Shareholders, Notice of AGM & Proxy Form
14/10/22 download Created with Sketch. 854.98KB
ACW ACW clinical biomarker study webcast presentation
10/10/22PRICE SENSITIVE download Created with Sketch. 2.4MB
ACW ACW announces positive Alzheimers Disease clinical results
10/10/22PRICE SENSITIVE download Created with Sketch. 300.23KB
ACW Trading Halt
06/10/22PRICE SENSITIVE download Created with Sketch. 272.6KB
ACW Date of AGM and Closing Date for Director Nominations
28/09/22 download Created with Sketch. 204.74KB
ACW Actinogen AD Biomarkers Context & History Presentation
13/09/22 download Created with Sketch. 2.94MB
ACW Appendix 4G
25/08/22 download Created with Sketch. 285.67KB
ACW Corporate Governance Statement
25/08/22 download Created with Sketch. 380.16KB
ACW Actinogen FY22 Results - Accelerating Clinical Development
25/08/22PRICE SENSITIVE download Created with Sketch. 254.15KB
ACW ACW Appendix 4E and 2022 Annual Report
25/08/22PRICE SENSITIVE download Created with Sketch. 4.92MB
ACW Actinogen Spark Plus non deal roadshow investor presentation
11/08/22 download Created with Sketch. 1.9MB
ACW Actinogen Clinical Trials Science Forum presentation slides
03/08/22 download Created with Sketch. 5.15MB
ACW ACW CEO presentation to Spark Plus Aust Equities Day
28/07/22 download Created with Sketch. 3.3MB
ACW Quarterly Activity Report & Appendix 4C
28/07/22PRICE SENSITIVE download Created with Sketch. 348.85KB
ACW ACW CEO to present at Spark Plus Aust Equities Day
25/07/22 download Created with Sketch. 218.79KB
ACW Actinogen Clinical Trials Science Forum Save the Date
21/07/22 download Created with Sketch. 217.82KB
ACW Application for quotation of securities - ACW
15/07/22 download Created with Sketch. 26.29KB
ACW Actinogen Alzheimer Disease Biomarker Study Timing & Design
13/07/22 download Created with Sketch. 257.67KB
ACW ACW Presentation for BIO International Convention meetings
14/06/22 download Created with Sketch. 4.01MB
ACW ACW announces Phase 2 trial designs for AD & MDD
14/06/22PRICE SENSITIVE download Created with Sketch. 556.64KB
ACW Change in substantial holding
01/06/22 download Created with Sketch. 181.96KB
ACW Application for quotation of securities - ACW
24/05/22 download Created with Sketch. 26.8KB
ACW Appendix 3Y - Dr Geoff Brooke
24/05/22 download Created with Sketch. 192.25KB
ACW Appendix 3Y - Dr Steven Gourlay
13/05/22 download Created with Sketch. 191.3KB
ACW Actinogen presentation to Bioshares Biotech Summit 2022
11/05/22 download Created with Sketch. 2.33MB
ACW Actinogen trial results & strategic update presentation
04/05/22PRICE SENSITIVE download Created with Sketch. 2.29MB
ACW Actinogen prioritizes Alzheimers Disease & Depression
04/05/22PRICE SENSITIVE download Created with Sketch. 243.81KB
ACW Quarterly Activity Report & Appendix 4C
28/04/22PRICE SENSITIVE download Created with Sketch. 814.14KB
ACW ACW positive XanaMIA results webcast slide presentation
27/04/22PRICE SENSITIVE download Created with Sketch. 2.07MB
ACW ACW announces positive XanaMIA results for Xanamem
27/04/22PRICE SENSITIVE download Created with Sketch. 250.85KB
ACW Trading Halt
22/04/22PRICE SENSITIVE download Created with Sketch. 679.48KB
ACW Appendix 3Y - Dr Steven Gourlay
06/04/22 download Created with Sketch. 190.89KB
ACW Cleansing Notice
06/04/22 download Created with Sketch. 341.02KB
ACW Application for quotation of securities - ACW
06/04/22 download Created with Sketch. 24.66KB
ACW Results of Meeting
05/04/22 download Created with Sketch. 222.14KB
ACW Letter to Shareholders & Notice of General Meeting
02/03/22 download Created with Sketch. 873.76KB
ACW ACW CEO Presents at European Life Sciences Conference
01/03/22 download Created with Sketch. 2.21MB
ACW Appendix 4D & Half-Year Financial Statements
24/02/22PRICE SENSITIVE download Created with Sketch. 975.13KB
ACW Actinogen appoints Prof Paul Rolan as Chief Medical Officer
15/02/22 download Created with Sketch. 232.96KB
ACW Actinogen XanaMIA Part A trial results expected in April
11/02/22PRICE SENSITIVE download Created with Sketch. 256.29KB
ACW Actinogen appoints XanaFX Phase 2 trial manager
09/02/22PRICE SENSITIVE download Created with Sketch. 259.28KB
ACW Quarterly Activity Report & Appendix 4C
28/01/22PRICE SENSITIVE download Created with Sketch. 496.77KB
ACW Application for quotation of securities - ACW
13/01/22 download Created with Sketch. 26.3KB
ACW ACW CEO Presents at San Francisco Healthcare Conference
10/01/22 download Created with Sketch. 7.51MB
ACW Appendix 3Y - Mr Malcolm McComas
21/12/21 download Created with Sketch. 192.48KB
ACW Appendix 3Y - Dr George Morstyn
21/12/21 download Created with Sketch. 192.27KB
ACW Appendix 3Y - Dr Geoff Brooke
21/12/21 download Created with Sketch. 192.49KB
ACW Application for quotation of securities - ACW
20/12/21 download Created with Sketch. 24.78KB
ACW Capital Raising Completion
20/12/21PRICE SENSITIVE download Created with Sketch. 236KB
ACW New clinical advisory boards
09/12/21 download Created with Sketch. 252.73KB
ACW ACW Strategic Collaboration with Oxford Uni Researchers
07/12/21PRICE SENSITIVE download Created with Sketch. 180.98KB
ACW Cleansing Notice
01/12/21 download Created with Sketch. 246.86KB
ACW Application for quotation of securities - ACW
30/11/21 download Created with Sketch. 23.42KB
ACW Offer to Participate in Share Purchase Plan
29/11/21 download Created with Sketch. 262.44KB
ACW Share Purchase Plan Offer Booklet
29/11/21 download Created with Sketch. 305.76KB
ACW Cleansing Notice - Share Purchase Plan
29/11/21 download Created with Sketch. 237.75KB
ACW XanaMIA Part A trial achieves target enrolment
29/11/21PRICE SENSITIVE download Created with Sketch. 204.1KB
ACW Cleansing Notice - Share Purchase Plan
25/11/21 download Created with Sketch. 224.16KB
ACW Proposed issue of securities - ACW
25/11/21 download Created with Sketch. 36.97KB
ACW Strategic Update & Capital Raising Investor Presentation
25/11/21PRICE SENSITIVE download Created with Sketch. 6.5MB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
2.8¢
Change
0.001(3.70%)
Mkt cap ! $88.91M
Open High Low Value Volume
2.8¢ 2.9¢ 2.8¢ $80.40K 2.835M

Buyers (Bids)

No. Vol. Price($)
3 876045 2.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 238911 3
View Market Depth
Last trade - 16.10pm 11/09/2025 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.